SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-10-015401
Filing Date
2010-03-24
Accepted
2010-03-24 17:02:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 v178435_13d.htm SC 13D 79918
2 v178435_ex1.htm EX-99.1 41931
  Complete submission text file 0001144204-10-015401.txt   123627
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Subject) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85384 | Film No.: 10702342
SIC: 4731 Arrangement of Transportation of Freight & Cargo

Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address
Brooke Robert T. (Filed by) CIK: 0001483808 (see all company filings)

Type: SC 13D